Literature DB >> 25277262

Discovery of a reductase-producing strain recombinant E. coli CCZU-A13 using colorimetric screening and its whole cell-catalyzed biosynthesis of ethyl (R)-4-chloro-3-hydroxybutanoate.

Yu-Cai He1, Dan-Ping Zhang2, Zhi-Cheng Tao2, Xian Zhang3, Zhen-Xing Yang2.   

Abstract

An NADH-dependent reductase (SsCR) was discovered by genome data mining. After SsCR was overexpressed in E. coli BL21, recombinant E. coli CCZU-A13 with high reductase activity and excellent stereoselectivity for the reduction of ethyl 4-chloro-3-oxobutanoate (COBE) into ethyl (R)-4-chloro-3-hydroxybutanoate ((R)-CHBE) was screened using one high-throughput colorimetric screening strategy. After the reaction optimization, a highly stereoselective bioreduction of COBE into (R)-CHBE (>99% ee) with the resting cells of E. coli CCZU-A13 was successfully demonstrated in n-butyl acetate-water (10:90, v/v) biphasic system. Biotransformation of 600mM COBE for 8h in the biphasic system, (R)-CHBE (>99% ee) could be obtained in the high yield of 100%. Moreover, the broad substrate specificity in the reduction of aliphatic and aromatic carbonyl compounds was also found. Significantly, E. coli CCZU-A13 shows high potential in the industrial production of (R)-CHBE (>99% ee) and its derivatives.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Asymmetric bioreduction; Biphasic system; Ethyl (R)-4-chloro-3-hydroxybutanoate; Ethyl 4-chloro-3-oxobutanoate; Recombinant E. coli CCZU-A13

Mesh:

Substances:

Year:  2014        PMID: 25277262     DOI: 10.1016/j.biortech.2014.09.062

Source DB:  PubMed          Journal:  Bioresour Technol        ISSN: 0960-8524            Impact factor:   9.642


  1 in total

1.  Biosynthesis of ethyl (S)-4-chloro-3-hydroxybutanoate with an NADH-dependent reductase (ClCR) discovered by genome data mining using a modified colorimetric screening strategy.

Authors:  Yu-Cai He; Dan-Ping Zhang; Yun Lu; Zhi-Cheng Tao; Yun Ding; Li-Qun Wang; Feng Liu
Journal:  Bioengineered       Date:  2015-02-27       Impact factor: 3.269

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.